Pacific Biosciences of California, Inc. Message Board

Search
Current Board
All Boards
Advanced Search
  • Subject Message Body
  • Topics Only Topics And Messages
  • codyoot codyoot • Oct 28, 2012 12:50 PM Flag

    sales projection by the end of 2013

    q3 2012, 4 bookings; q4 2012, 6 bookings; q1 2013, 9 bookings, q2 2013, 12 bookings; q3 2013, 20 bookings; q4 2013, 30 bookings. that's a total of 72.

    72 X $700000=50.4 million.

    assume revenue from consumables and service is 4 million/quarter.

    4 million x 5q=20 million.

    assume the cash burn rate keeps flat at 20 million per quarter,

    20 x 5q= 100 million.

    then by the end of 2013, we will have 120 -100 +50.4 +20 = 90 million cash in hand.

    so we are looking good, no need for raising cash again, Pacb will easily turn the corner!

    Sentiment: Strong Buy

    Sort:  Newest  |  Oldest  |  Most Replied Expand all replies
    • rwikle@bellsouth.net rwikle • Oct 31, 2012 8:53 AM Flag

      where did you dream up these numbers? ILMN is eating PACB's lunch. Those that have bought regret the decision. Mean time to repair is abysmal and service contracts are through the roof!

      Sentiment: Sell

      • 1 Reply to rwikle
      • codyoot codyoot • Oct 31, 2012 10:07 AM Flag

        you idiot don't know any science behind these sequencing technologies, ILMN will eventually be replaced by PACB, trust me. just follow the number of scientific paper published by using pacbio, it will grow exponentially. SMRT sequencing will reach 10kb average reads soon, that's a great advantage for de novo assemble, SMRT will be used in new born screen. SMRT can also do lots of base modification analysis, which will be the next big thing in genomic research. ILMN reads stop at an average of 150 bp, and that's it.

Back To Board
Previous topic Next topic
New Topic
 
PACB
2.540.04(+1.60%)May 21 4:00 PMEDT